NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 69 filers reported holding NEOGENOMICS INC in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $349,000 | +24.2% | 31,371 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $281,000 | +13.3% | 31,371 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $248,000 | -14.5% | 31,371 | -7.3% | 0.00% | 0.0% |
| Q4 2016 | $290,000 | 0.0% | 33,848 | -4.2% | 0.00% | 0.0% |
| Q3 2016 | $290,000 | +2.1% | 35,329 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $284,000 | +22.9% | 35,329 | +2.9% | 0.00% | 0.0% |
| Q1 2016 | $231,000 | -15.7% | 34,331 | -1.3% | 0.00% | 0.0% |
| Q4 2015 | $274,000 | +41.2% | 34,791 | +2.5% | 0.00% | 0.0% |
| Q3 2015 | $194,000 | +5.4% | 33,943 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $184,000 | +106.7% | 33,943 | +32.7% | 0.00% | – |
| Q1 2014 | $89,000 | -6.3% | 25,574 | -2.3% | 0.00% | – |
| Q4 2013 | $95,000 | +20.3% | 26,169 | 0.0% | 0.00% | – |
| Q3 2013 | $79,000 | +92.7% | 26,169 | +152.2% | 0.00% | – |
| Q2 2013 | $41,000 | – | 10,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |